HealthRX vs Hers: Which GLP-1 Provider Is Better?
Short answer: Hers scores higher on our rubric, 5.3/10 against 5.2/10. Full reasoning, pricing and the cases where the other one wins are below.
Hers beats HealthRX overall, scoring 5.3/10 vs 5.2/10. Published pricing is not a like-for-like monthly comparison: HealthRX is from $99/mo; Hers is $188 first month, then $298/mo. Choose HealthRX for cash-pay patients who want low flat-dose compounded glp-1 pricing, all-50-state access, fast shipping, and self-service cancellation. Choose Hers for women who want a female-focused platform and can budget at least $188 initially and $298/mo ongoing for a $149 medication path.
A side-by-side look at HealthRX and Hers to help you decide. We compare them on:
- •Starting price per month
- •Our overall score, out of 10
- •Medication type, brand-name or compounded
- •Whether they accept insurance
- •Who each one is best for
HealthRX
#49 of 54HealthRX is a cash-pay telehealth platform for compounded injectable semaglutide and tirzepatide. Its July 2026 landing page lists semaglutide at $133/mo on a 3-month plan or $99/mo on a 12-month plan, plus tirzepatide at $209/mo or $179/mo. Prices stay flat across doses and include clinician review, dose adjustments, and overnight shipping. MD Integrations supplies the clinician network, while the dispensing 503A pharmacy remains unnamed on the public site.
Visit HealthRXHers
#46 of 54The women's health arm of Hims & Hers Health (NYSE: HIMS). Hers lists Wegovy pill, Foundayo, and Ozempic pill medication from $149, a Wegovy pen from $199, Zepbound from $299, and compounded options. A required Weight Loss Membership adds $39 in month one and $149/mo thereafter, so the all-in floor for a $149 medication path is $188 initially and $298/mo ongoing; exact product and dose prices vary.
Visit Hers| Feature | HealthRX | Hers |
|---|---|---|
| Why each one | Low flat-dose pricing paired with linked LegitScript verification, nationwide clinician coverage, overnight shipping, and self-service account cancellation. | A major women-focused telehealth platform with a direct Novo Nordisk partnership (Wegovy pill from $149 and pen from $199 before required membership) and a Lilly partnership (Zepbound medication from $299) alongside compounded options. |
| Our Score | 5.2/10 | 5.3/10 |
| Headline Price | from $99/mo | $188 first month, then $298/mo |
| Medication Type | Compounded | Both |
| Insurance Accepted | No | No |
| Best For | Cash-pay patients who want low flat-dose compounded GLP-1 pricing, all-50-state access, fast shipping, and self-service cancellation | Women who want a female-focused platform and can budget at least $188 initially and $298/mo ongoing for a $149 medication path |
| Watch out for | The dispensing 503A pharmacy is described by type while its name and license remain absent from the public site | Pending federal enforcement action against the parent company. On July 29, 2026 the FTC, joined by Utah and California acting through Los Angeles County Counsel, filed a complaint against Hims & Hers Health, Inc. in the U.S. District Court for the Northern District of California, alleging violations of the FTC Act and the Restore Online Shoppers' Confidence Act over subscription billing, cancellation friction, and sharing consumer health information with advertising platforms. Case status is Pending. These are allegations, not findings. |
| Ranking | #49 | #46 |
| Get started | Visit HealthRX | Visit Hers |
Pros & Cons Compared
HealthRX
Pros
- +$99/mo compounded semaglutide on the 12-month plan, with a $133/mo 3-month option
- +Flat pricing across doses, clinician review, dose adjustments, and overnight shipping included
- +Licensed clinicians in all 50 states through MD Integrations, with most files reviewed within about 24 hours
- +LegitScript certificate 50087439 links to the issuer's verification checker
- +Single-click account cancellation and refunds for unshipped doses
- +Published HIPAA notice, telehealth consent, safety information, and emergency instructions
Cons
- −The dispensing 503A pharmacy is described by type while its name and license remain absent from the public site
- −Legal entity, headquarters, executive team, and medical director remain undisclosed
- −The tirzepatide product page advertises $149/mo while the current affiliate landing and FAQ say $179/mo, so confirm the checkout rate
- −The 4.8/5 from 12,000+ members block uses illustrative composites rather than an independent review platform
- −Cash-pay only, with no insurance billing or prior-authorization support
- −Compounded medications sit outside FDA premarket approval as finished products
Hers
Pros
- +FDA-approved brand paths include Wegovy pill, Foundayo, and Ozempic pill medication from $149 and a Wegovy pen from $199; with the required membership, a $149 medication path totals $188 initially and $298/mo ongoing
- +Zepbound access via the Lilly/Hims-Hers partnership announced 2026
- +Publicly traded company (NYSE: HIMS) with strong financial backing and regulatory compliance
- +Broader women's health platform, integrates weight loss with hormonal, skin, and wellness services
Cons
- −Pending federal enforcement action against the parent company. On July 29, 2026 the FTC, joined by Utah and California acting through Los Angeles County Counsel, filed a complaint against Hims & Hers Health, Inc. in the U.S. District Court for the Northern District of California, alleging violations of the FTC Act and the Restore Online Shoppers' Confidence Act over subscription billing, cancellation friction, and sharing consumer health information with advertising platforms. Case status is Pending. These are allegations, not findings.
- −Every medication figure excludes the required Weight Loss Membership ($39 first month, then $149/mo); exact product and dose prices can increase the total above the $188/$298 floor
- −Support runs at big-platform scale, fine for routine refills, less personal if you want high-touch care
- −Compounded pricing starts at $199/mo with stepped pricing at higher doses, budget for the dose you'll end up on, not the entry dose
- −Zepbound medication starts at $299 before the required membership; that path totals $338 in month one and at least $448/mo ongoing, with exact dose pricing potentially higher
Our Verdict
Hers edges out HealthRX with a score of 5.3/10 vs 5.2/10. Published pricing is not a like-for-like monthly comparison: HealthRX is from $99/mo; Hers is $188 first month, then $298/mo. Hers offers both brand-name and compounded medications, giving you more flexibility.
Read Full Reviews
Related comparisons
More head-to-head comparisons involving HealthRX and Hers.
Not comparing, just asking? Quick answers to the most-asked GLP-1 questions →
- Compare HealthRX and Embodyfrom $69/mo
- Compare HealthRX and Yucca Healthfrom $125/mo
- Compare HealthRX and Wellorithm$147 first month, rises after
- Compare Hers and Sprout Health$110/mo flat
- Compare Hers and Fridaysfrom $117/mo
- Compare Hers and Eden Health GLP-1$99/mo month-to-month
Not sure which one is right for you?
Answer a few quick questions and we'll match you to the best GLP-1 provider for your needs. Or keep exploring below.
Still working out whether either one is above board? We check that separately: is Hers legit, with the verification evidence behind each answer.
Our pick of these two: Hers · 5.3/10